Financial statements Symbiofarm

Balance sheet of Symbiofarm

Company age:
Age:
14 y. 2 m. 6 d.
Share capital:
Share capital:
6 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of SYMBIOFARM

Year
2018
2019
2020
2021
2022
2023
Total assets 17 785 521,20 20 826 931,75 24 154 988,14 23 754 507,24 22 138 360,03 23 739 414,93
A. Fixed assets 1 126 248,51 1 214 859,76 1 193 628,58 3 444 977,46 3 163 393,39 3 043 154,47
B. Current assets 16 659 272,69 19 612 071,99 22 961 359,56 20 309 529,78 18 974 966,64 20 696 260,46
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 17 785 521,20 20 826 931,75 24 154 988,14 23 754 507,24 22 138 360,03 23 739 414,93
A. Equity 14 568 382,98 14 248 154,33 18 241 109,08 15 482 199,05 14 414 798,04 15 713 707,12
B. Liabilities and provisions for liabilities 3 217 138,22 6 578 777,42 5 913 879,06 8 272 308,19 7 723 561,99 8 025 707,81
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 2 921 938,05 6 452 400,16 5 851 869,60 8 243 968,84 7 673 279,97 7 479 567,88
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.